General Information of the Cell Line
Cell Line ID
CL000962
Cell Line Name
NCI-H2009
Synonyms
H2009
H-2009
NCIH2009
Category
Cancer cell line
Organism
Homo sapiens (Human)
Tissue Information
Lymph node
Disease
Lung adenocarcinoma (NCIt: C3512)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01587, Stearoyl-CoA desaturase
Compound ID Compound Name Compound Formula
CP0554252
4-benzoyl-N-(6-propoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C24H20N2O3S
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0554255
1-N-benzyl-4-N-(6-methoxy-1,3-benzothiazol-2-yl)benzene-1,4-dicarboxamide
   Show/Hide
C23H19N3O3S
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0554253
4-benzoyl-N-(6-prop-2-ynoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C24H16N2O3S
 1
1
IC50 = 90 nM
   TI
   LI
   LO
   TS
CP0571402
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-(piperidine-1-carbonyl)benzamide
   Show/Hide
C21H21N3O3S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0525889
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-(pyridine-3-carbonyl)benzamide
   Show/Hide
C21H15N3O3S
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0525885
N-(1H-benzimidazol-2-yl)-4-benzoylbenzamide
   Show/Hide
C21H15N3O2
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0420964
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-(pyridine-2-carbonyl)benzamide
   Show/Hide
C21H15N3O3S
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0525884
N-(1,3-benzothiazol-2-yl)-4-benzoylbenzamide
   Show/Hide
C21H14N2O2S
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0576700
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-nitrobenzamide
   Show/Hide
C15H11N3O4S
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0572230
4-benzoyl-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C22H16N2O3S
 1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0420968
4-benzoyl-N-(5-phenyl-1,3-thiazol-2-yl)benzamide
   Show/Hide
C23H16N2O2S
 1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0402418
N-(5-methoxy-1,3-benzothiazol-2-yl)-4-nitrobenzamide
   Show/Hide
C15H11N3O4S
 1
1
IC50 = 5500 nM
   TI
   LI
   LO
   TS
CP0538399
4-[(S)-amino(phenyl)methyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C22H19N3O2S
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0532067
4-benzoyl-N-(5-bromo-6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C22H15BrN2O3S
 1
1
IC50 = 6900 nM
   TI
   LI
   LO
   TS
CP0525888
4-anilino-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C21H17N3O2S
 1
1
IC50 = 8900 nM
   TI
   LI
   LO
   TS
CP0547308
4-benzoyl-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
   Show/Hide
C23H16N2O2S
 1
1
IC50 = 14900 nM
   TI
   LI
   LO
   TS
CP0402416
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-phenylmethoxybenzamide
   Show/Hide
C22H18N2O3S
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0420966
N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C15H12N2O2S
 1
1
IC50 = 21000 nM
   TI
   LI
   LO
   TS
CP0517248
3-methoxy-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C16H14N2O3S
 1
1
IC50 = 21000 nM
   TI
   LI
   LO
   TS
CP0517765
N-(1,3-benzothiazol-2-yl)-4-nitrobenzamide
   Show/Hide
C14H9N3O3S
 1
1
IC50 = 22000 nM
   TI
   LI
   LO
   TS
CP0532068
4-amino-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C15H13N3O2S
 1
1
IC50 = 22000 nM
   TI
   LI
   LO
   TS
CP0053280
4-fluoro-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C15H11FN2O2S
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0402420
N-(6-methoxy-1,3-benzothiazol-2-yl)-3-methylbenzamide
   Show/Hide
C16H14N2O2S
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0532065
N-(1,3-benzothiazol-2-yl)-4-methoxybenzamide
   Show/Hide
C15H12N2O2S
 1
1
IC50 = 31000 nM
   TI
   LI
   LO
   TS
CP0547307
N-(6-methoxy-1,3-benzothiazol-2-yl)pyridine-3-carboxamide
   Show/Hide
C14H11N3O2S
 1
1
IC50 = 37000 nM
   TI
   LI
   LO
   TS
CP0278072
4-methoxy-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C16H14N2O3S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0420963
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-(morpholine-4-carbonyl)benzamide
   Show/Hide
C20H19N3O4S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0420969
4-benzoyl-N-[6-(2-bromoethoxy)-1,3-benzothiazol-2-yl]benzamide
   Show/Hide
C23H17BrN2O3S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0525890
N-(1,3-benzothiazol-2-yl)-4-phenylbenzamide
   Show/Hide
C20H14N2OS
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0532064
4-azido-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C15H11N5O2S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0532069
4-benzoyl-N-(1,3-thiazol-2-yl)benzamide
   Show/Hide
C17H12N2O2S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0554250
N-(1,3-benzothiazol-2-yl)-3-methylbenzamide
   Show/Hide
C15H12N2OS
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0554251
N-(5-amino-1,3-benzothiazol-2-yl)-4-methoxybenzamide
   Show/Hide
C15H13N3O2S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0554265
N-(1,3-benzothiazol-2-yl)pyridine-3-carboxamide
   Show/Hide
C13H9N3OS
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0568805
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-(4-methylpiperazine-1-carbonyl)benzamide
   Show/Hide
C21H22N4O3S
 1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0420962
4-[(R)-amino(phenyl)methyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)benzamide
   Show/Hide
C22H19N3O2S
 1
1
IC50 >= 1100 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0160473
2-(4-(2-(1H-pyrazol-3-ylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)acetonitrile
   Show/Hide
C16H14N10  1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Lymph node)
Cell Line Name Organism Disease
AN3-CA Homo sapiens (Human) Acanthosis nigricans--NCIt; C7359; Endometrial adenocarcinoma
A2058 Homo sapiens (Human) Amelanotic melanoma
LOX-IMVI Homo sapiens (Human) Amelanotic melanoma
SW620 Homo sapiens (Human) Colon adenocarcinoma
SW620/AD300 Homo sapiens (Human) Colon adenocarcinoma
LoVo Homo sapiens (Human) Colon adenocarcinoma
SK-MEL-5 Homo sapiens (Human) Cutaneous melanoma
SU-DHL-5 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HOC313 Homo sapiens (Human) Floor of mouth squamous cell carcinoma
HGC-27 Homo sapiens (Human) Gastric carcinoma
NUGC-4 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
NCI-H1993 Homo sapiens (Human) Lung adenocarcinoma
PC-9 Homo sapiens (Human) Lung adenocarcinoma
NCI-H838 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1568 Homo sapiens (Human) Lung adenocarcinoma
PC9-DRH Homo sapiens (Human) Lung adenocarcinoma
NCI-H1299 Homo sapiens (Human) Lung large cell carcinoma
NCI-H1155 Homo sapiens (Human) Lung large cell carcinoma
NCI-H292 Homo sapiens (Human) Lung mucoepidermoid carcinoma
HBL-2 [Human mantle cell lymphoma] Homo sapiens (Human) Mantle cell lymphoma
MNT-1 Homo sapiens (Human) Melanoma
JR8 Homo sapiens (Human) Melanoma
MM96L Homo sapiens (Human) Melanoma
WM3629 Homo sapiens (Human) Melanoma
L3.6pl Homo sapiens (Human) Pancreatic adenosquamous carcinoma
LNCaP Homo sapiens (Human) Prostate carcinoma
LAPC-4 Homo sapiens (Human) Prostate carcinoma
LNCaP-AR Homo sapiens (Human) Prostate carcinoma
LNCaP C4-2 Homo sapiens (Human) Prostate carcinoma
MR49F Homo sapiens (Human) Prostate carcinoma
LNCaP-hr Homo sapiens (Human) Prostate carcinoma
LNCap-ARR2PB-eGFP Homo sapiens (Human) Prostate carcinoma
Th17 Mus musculus (Mouse) -